Your browser doesn't support javascript.
loading
Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.
Wopperer, Florian J; Knaup, Karl X; Stanzick, Kira J; Schneider, Karen; Jobst-Schwan, Tilman; Ekici, Arif B; Uebe, Steffen; Wenzel, Andrea; Schliep, Stefan; Schürfeld, Carsten; Seitz, Randolf; Bernhardt, Wanja; Gödel, Markus; Wiesener, Antje; Popp, Bernt; Stark, Klaus J; Gröne, Hermann-Josef; Friedrich, Björn; Weiß, Martin; Basic-Jukic, Nikolina; Schiffer, Mario; Schröppel, Bernd; Huettel, Bruno; Beck, Bodo B; Sayer, John A; Ziegler, Christine; Büttner-Herold, Maike; Amann, Kerstin; Heid, Iris M; Reis, André; Pasutto, Francesca; Wiesener, Michael S.
Afiliación
  • Wopperer FJ; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; Research Center on Rare Kidney Diseases (RECORD), University Hospital Erlangen, Erlangen, Germany.
  • Knaup KX; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Stanzick KJ; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
  • Schneider K; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Jobst-Schwan T; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; Research Center on Rare Kidney Diseases (RECORD), University Hospital Erlangen, Erlangen, Germany.
  • Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Uebe S; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Wenzel A; Institute of Human Genetics, Center for Molecular Medicine Cologne (CMMC), and Center for Rare Disease (ZSEK), University Hospital of Cologne, Cologne, Germany.
  • Schliep S; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Schürfeld C; Gesundheitszentrum Vauban, Saarlouis, Germany.
  • Seitz R; Department of Nephrology and Hypertension, Klinikum Neumarkt, Neumarkt, Germany.
  • Bernhardt W; Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen, Hannover, Germany.
  • Gödel M; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wiesener A; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Popp B; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; Institute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig, Germany.
  • Stark KJ; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
  • Gröne HJ; Medical Faculty, University of Heidelberg, Heidelberg, Germany; Institute of Pharmacology, University of Marburg, Marburg, Germany.
  • Friedrich B; Nephrologisches Zentrum Böblingen Leonberg Herrenberg, Leonberg, Germany.
  • Weiß M; Walddörfer-Dialyse, Hamburg, Germany.
  • Basic-Jukic N; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Schiffer M; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Schröppel B; Sektion Nephrologie, Klinik für Innere Medizin I, Universität Ulm, Ulm, Germany.
  • Huettel B; The Max Planck-Genome-Centre Cologne, Max Planck Institute for Plant Breeding Research, Cologne, Germany.
  • Beck BB; Institute of Human Genetics, Center for Molecular Medicine Cologne (CMMC), and Center for Rare Disease (ZSEK), University Hospital of Cologne, Cologne, Germany.
  • Sayer JA; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Ziegler C; Department of Biophysics, University of Regensburg, Regensburg, Germany.
  • Büttner-Herold M; Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Amann K; Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Heid IM; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
  • Reis A; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Pasutto F; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Wiesener MS; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. Electronic address: michael.wiesener@uk-erlangen.de.
Kidney Int ; 102(2): 405-420, 2022 08.
Article en En | MEDLINE | ID: mdl-35643372
ABSTRACT
Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is caused by mutations in one of at least five genes and leads to kidney failure usually in mid adulthood. Throughout the literature, variable numbers of families have been reported, where no mutation can be found and therefore termed ADTKD-not otherwise specified. Here, we aim to clarify the genetic cause of their diseases in our ADTKD registry. Sequencing for all known ADTKD genes was performed, followed by SNaPshot minisequencing for the dupC (an additional cytosine within a stretch of seven cytosines) mutation of MUC1. A virtual panel containing 560 genes reported in the context of kidney disease (nephrome) and exome sequencing were then analyzed sequentially. Variants were validated and tested for segregation. In 29 of the 45 registry families, mutations in known ADTKD genes were found, mostly in MUC1. Sixteen families could then be termed ADTKD-not otherwise specified, of which nine showed diagnostic variants in the nephrome (four in COL4A5, two in INF2 and one each in COL4A4, PAX2, SALL1 and PKD2). In the other seven families, exome sequencing analysis yielded potential disease associated variants in novel candidate genes for ADTKD; evaluated by database analyses and genome-wide association studies. For the great majority of our ADTKD registry we were able to reach a molecular genetic diagnosis. However, a small number of families are indeed affected by diseases classically described as a glomerular entity. Thus, incomplete clinical phenotyping and atypical clinical presentation may have led to the classification of ADTKD. The identified novel candidate genes by exome sequencing will require further functional validation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Riñón Poliquístico Autosómico Dominante / Enfermedades Renales Poliquísticas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Riñón Poliquístico Autosómico Dominante / Enfermedades Renales Poliquísticas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article País de afiliación: Alemania